This Seminar will cover the law on confidentiality of substance use disorder patient records under 42 CFR part 2. This law was previously known as the confidentiality of drug abuse and alcohol abuse records.
The new law originally was effective in 2017 and a second law was effective February 2, 2018. Updates occurred in 2020 and hospitals are still struggling to determine what they need to do to meet compliance.
Anyone or any facility that is subject to these requirements needs to attend this Seminar. All hospitals should have a policy and this program will address what needs to be in the policy. This is true even for hospitals that do not have dedicated units to treat patients with drug and alcohol problems, now known as substance abuse disorders. Changes and updates implemented in 2020 will also be discussed.
The Seminar will discuss what is required of part 2 programs. A facility that receives federal assistance (such as Medicare) and hold itself out as providing substance use disorder diagnosis, treatment, or referral must follow these extensive regulations. They address the notice that must be given to the patient. It discusses patient access to medical records and what must be in the consent form.
It discusses research, closure of a program, new definitions, minors, decease patient records, security of medical records, disclosure, when disclosure is prohibited, and more.
Why you should Attend:
Uncertainty, Unawareness of federal regulations regarding Substance Use Disorder medical records.
Areas Covered in the Session: